CONTRATOS ARTICULO 60 LOSU
Kontratua
Experience In The Field of On Potential Indications of Molecules That Inhibit Nlrp3 And Potential Techniques To Use In The Design of Drugs That Inhibit Nlrp3.
Finantzatzailea:
GLENMARK PHARMACEUTICALS LIMITED
date_range
Iraupena 2021(e)ko apirila-(a)k 22-(e)tik 2022(e)ko apirila-(a)k 22-(e)ra izan da
(12 months)
euro
607,50 EUR
Nazioarteko (UE ez)-arlokoak. Izaera Pribatua-arekin.
Ikertzaileak
Pablo
Pelegrin Vivancos
Arduraduna